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The incidence of inflammatory bowel diseases (IBD), including ulcerative colitis (UC), 
is on the rise. UC is modeled in rodents by the consumption of dextran sodium sulfate 
(DSS). Quantitative real-time polymerase chain reaction (qPCR) is a sensitive technique 
used to quantify the abundance of “target gene sequences”, including those that may be 
related to the causation of UC.  Using Lactobacillus-group-specific primers, qPCR was 
used to determine the abundance of Lactobacillus species found in the feces of both 
DSS-treated (n=4) and untreated control rats (n=6).  DNA isolated from the feces of 
untreated control rats yielded strong and reproducible qPCR signals, whereas DNA 
isolated from the feces of DSS-treated rats often failed to produce detectable qPCR 
signals. We hypothesized that DSS co-purified with the extracted DNA and reduced 
PCR efficiency by either (i) competing with DNA for the Taq DNA polymerase active 
site or (ii) binding and modifying the polymerase.  To test this hypothesis, we conducted 
  iv 
DSS-spiking studies and employed a number of techniques to remove residual DSS.  We 
confirm here that DSS is indeed responsible for the observed qPCR failure and that the 
Dneasy Blood and Tissue Kit (Qiagen) was most effective in removing residual DSS and 
restoring PCR efficiency.  
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Ct  Cycle threshold 
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CHAPTER I 
INTRODUCTION 
1.1 Ulcerative colitis  
Ulcerative Colitis (UC) is a chronic inflammatory condition of the large intestine (8). In 
the period 1984-1993, UC affected only 8 out of 100,000 people in the United States.  In 
2001, however, the incidence had increased to 246 cases per 100,000 (10).  Emerging 
evidence indicates a positive correlation between the incidences of reoccurring 
ulcerative colitis and colon cancer (3, 12). The aetiology of the disease is unknown; 
however, the presence of a luminal commensal microbiota is known to be vital for the 
initiation and progression of the disease in both chemically-induced and spontaneous 
models of colitis (7).  Dextran Sodium Sulfate (DSS) is a well established model used to 
mimic human UC in rodents and has been used to study the effects of inflammation on 
the gastrointestinal (GI) microbiota (11, our unpublished results).  Traditionally, culture-
based methods have been used to study microbial communities; however, due to 
limitations of cultivation-dependent strategies, detection of viable but not cultivatable 
cells have lead to the use of modern culture-independent techniques (9).   
 
1.2 Quantitative real-time polymerase chain reaction  
A number of molecular techniques can be used to estimate the number of microbial cells 
including, randomly amplified polymorphic DNA (RAPD) polymerase chain reaction 
denaturing gel electrophoresis (PCR-DGGE).   
_______________ 
This thesis follows the style of Applied and Environmental Microbiology.  
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Accurate quantification of DNA can be also be rapidly and reproducibly obtained by 
quantitative real-time polymerase chain reaction (qPCR) (4).  Real-time PCR is a precise 
and sensitive technique which can detect minute changes by quantifying PCR products 
in “real-time” and eliminates down-stream processing (14).  The qPCR reaction is 
carried out in a thermocycler equipped with a fluorescence detector. SYBR® Green, 
which absorbs blue light at (λmax= 488nm) and emits green light at (λmax = 522nm) is a 
fluorophore and intercalating dye that is commonly used during qPCR (17).  When 
double-stranded DNA (dsDNA) dye, such as SYBR®Green (FIG. 1) bind to the double 
stranded anti-parallel DNA, the dye emits a fluorescence signal. Therefore, during qPCR 
reaction, increased fluorescence intensity is positively correlated to an increase in DNA 
product (14).  SYBR® Green binds to DNA non-specifically, meaning that it will bind 
the intended target amplicons, primer-dimers and unintended or non-specific PCR 
products.  The non-specific binding of the SYBR Green molecule can result in 
inaccurate quantification of the target (17), however it enables signal quantification in 
the absence of molecular probes (e.g. Taqman assays).  
 
In qPCR, amplification is detected in the log phase (FIG.2), also known as exponential 
phase by plotting copy number against cycle number (4).  Target Copy number is a 
measure of the DNA product obtained from amplification. The threshold line, an 
arbitrary number, is set at a specific copy number at which fluorescence is observed to 
increase above the background level.  The cycle threshold (Ct) value refers to the cycle 
number at which the fluorescence emitted from the sample crosses the threshold line (3). 
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Ct values are indirectly related to copy numbers.   Hereafter, the target DNA is 
quantitated against a calibration (standard) curve that connects threshold cycles to exact 
concentrations of sample DNA (9). 
  
  
   





















    Reverse Primer 
FIG. 1. SYBR® Green. The forward and reverse primers bind to the respective DNA strand. 
SYBR® Green binds which absorbs blue light at λ = 488nm and emits green light at λ = 522nm. 





1.3 DNA extraction, purity and concentration determination 
The presence of natural compounds, such as polysaccharides, fats, carbohydrates and 
proteins in samples may interfere with DNA extraction and affect down-stream 
processes including PCR amplification (15). As a result, these inhibitory substances 
must be removed from DNA-containing sample during extraction.  Nature of the DNA 
extraction kits vary in their removal efficiencies and this often depends on the DNA- 
containing sample being tested. Traditionally, a spectrophotometer is used to determine 
DNA purity by measuring the intensity of absorbance at 260nm and 280nm (2). An A 
260: A 280 ratio between 1.8-1.9 indicates highly purified DNA; whereas, a ratio less 
than 1.8 indicates protein contamination (2).  Unfortunately, co-purification of acidified 
polysaccharides, such as DSS cannot be detected using a spectrophotometrically. In this 





FIG. 2. Real-Time PCR Graph. The horizontal axis is the PCR cycle number while the vertical axis is 
the copy number (DNA product). The threshold line is set at the copy number at which fluorescence is 
observed to increase above the background level. The CT value is the copy number at which 
fluorescence crosses the threshold value. Source < http://www.rt-pcr.com/>    
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experiments, concentration of co-purified DSS which causes inhibition in qPCR was 
determined.  
 
1.4 Selecting target gene 
In order to determine the abundance of specific members of the intestinal microbiota 
using qPCR, an appropriate target gene/sequence must be selected (9).  The target gene 
should have variable and conserved regions discrimination of broad taxonomic levels, 
and provide annealing sites that enable the PCR primers, respectively (9).  The 16S 
rRNA gene is most commonly used gene target for a number of reasons.  It is universally 
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CHAPTER II 
METHODS 
2.1 Collection and storage of fecal material 
Our Animal Use Protocol (AUP) was reviewed and approved by the Institutional Animal 
Care and Use Committee (IACUC) prior to initiation of our study (Fig. 3).  Ten 
Weanling Sprague-Dawley mice were used as subjects of these, six served as negative 
control and four were administered with 3% DSS through their drinking water for 48 
hours. A 14-day period was present before the second course of DSS was administered 
(Fig. 3).  The mice were kept in individual hanging cages and under a 12-hour light/dark 
cycle. A paper sheet was placed under each cage to collect feces; papers were replaced. 
There were six collection events and fecal samples were collected every 3 hours during 





FIG. 3. Fecal Sample Collection Timeline.
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Fecal samples were collected in pre-labeled 15ml tubes and stored at -80°C.  Fecal 
samples were always kept on ice 
 
2.2 DNA extractions 
For each collection event, the weight of the fecal pellets was measured prior to 
extraction and recorded. 5ml of 10mM Tris (pH 8) was added to the fecal pellets which 
were homogenized using Fast Prep®-24 in 15 ml tubes. 0.5ml of fecal slurry was used 
for DNA extraction while the rest was frozen at -80°C freezer for future analysis.  
Bacterial DNA was extracted from homogenized fecal samples using the 
FastDNA®SPIN Kit for Soil according to manufacturer’s protocol.  In brief, samples 
were incubated for 5 minutes at 55°C to increase DNA yield. The NanoDrop™ 1000 
spectrophotometer (TheromoScientific) was used to determine DNA concentration and 
purity at 260/280 nm.  An aliquot of each sample was diluted to for 5ng/µl in 
DNase/Pyrogen-Free Water (DES). 
 
2.3 Quantitative real-time polymerase chain reaction   
SYBR® Green PCR reactions (25µl) were carried out in BIO-RAD iQ 96-well reaction 
plates in a BIO-RAD iCycler IQ5. PCR mixtures were composed of 12.5µl Quanta B-R 
SYBR® Green SuperMix for iQ*, 1µl of 5ng/µl DNA template, 9.5µl sterile Nanopure 
water, and 1µl of each 25µM Lac primer used for a final volume of 25µl (TABLE 1).  
Lactobacillus-group-specific primers Lac1 (5’AGCAGTAGGGAATCTTCCA-3’) and 
Lac2 (5’ATTYCACCGCTACACATG-3’) were used in the reaction. Each sample was 
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assayed in triplicates. Positive control reactions contained L. acidophilus (NCFM) as 
DNA template while the negative control reactions contained an equal volume of 
autoclaved Nanopure water.  The cycling conditions used were 3min at 95°C, 45 cycles 
of 15 s at 95°C, and 45 s at 60°C.  Amplification and data analysis were performed using 
the IQ™5 Optical System Software 2.0.  Gene copies per PCR reaction were calculated 
using a standard curve generated for the assay.  
 
 










2.4 Removal of inhibitory substances 
When appropriate, residual DSS was removed using the Fast DNA® Spin Kit for Soil on 
spiked DSS fecal material and control fecal material lacking DSS.  In order to determine 
the effects of DSS in relation to concentration, part of the extracted DNA was analyzed 
using qPCR, while the other part was further purified using Qiagen Dneasy Blood and 
Substance Quantity 
1X Quanta B-R SYBR® Green SuperMIX 12.5µl 
25µM Lac 1 Primer  1µl 
25µM Lac 2 Primer 1µl 
DNA Template (5ng/µl) 1µl 
Autoclaved, Nanopure Water 9.5µl 
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Tissue Kit and thereafter processed using qPCR (FIG. 4). The conditions used for qPCR 
were same as before.  DSS concentration of 3mg, 0.3mg, 0.03mg, 0.003mg and 0mg 
were dissolved in 100 µl water. The water replaced 100µl of the 900µl (1/9) sodium 
phosphate buffer used in the extraction process.  For each tested concentration, n=3.  The 
assay was repeated with DSS concentration of 300mg, 30mg, 3mg, 0.3mg and 0mg.  
Thereafter, Qiagen Dneasy Blood &Tissue Kit was used to remove DSS from the 
samples in the study.    
 






FIG. 4. Purification Process.  
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CHAPTER III 
RESULTS AND DISCUSSION 
The condition of human UC was mimicked in rodents using DSS in order to study its 
effects on the Lactobacillus population in the GI tract. Lactobacillus is part of the human 
intestinal microbiota; and a high count is considered to be beneficial to the host.  
Preliminary studies conducted on a rat’s fecal samples showed no significant difference 
within one sitting of pellets but, a difference was observed in the pellets collected during 
different sittings within a collection event. In order to obtain a representative sample of 
all the organisms present within the 24-hour period collection, one pellet from each time 
point was combined into a 2ml tube to make a master mix. This was to eliminate intra-
day variation and allow inter-day variation.  qPCR was used to amplify 16S rRNA genes 
and detect bacterial counts of Lactobacillus.  However, the two time points during which 
DSS was administered, day 21 and day 35, failed to amplify. Ct values > 30 indicated 
there was a significant inhibition and Ct value < 30 indicated successful amplification.  
We suspected that DSS had co-purified with DNA and was interfering in qPCR.  
Relative to the illustration (FIG.5), DSS time points show significantly lower copy 
numbers. Due to the observed qPCR inhibition from the DSS- treated time points, 
another purification step was performed in efforts of removing DSS.   
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FIG. 5. Unaltered DSS Time-Points. During day 21 and day 35 when DSS was administered, a low copy 
number/g fecal weight is observed. 
 
 
3.1 DSS spiking experiment 
To determine if DSS was indeed able to inhibit qPCR, DSS was spiked into 0.5g fecal 
samples at concentrations of 3, 0.3, 0.03, 0.003 and 0mg. Plate 1 used the non-Qiagen 
treated DNA template while plate 2 used the DNA obtained following the Qiagen 
purification.  Amplification was observed in Plate 1 (FIG A.1) for concentrations of 
0.03, 0.003, and 0mg whereas; concentrations of 3 and 0.03mg failed to amplify or 
amplified extremely late (TABLE A.1). The high Ct values observed display DSS is 
inhibitory at concentrations of 3 and 0.3 mg and could be co-eluted into the DNA 
samples during the first purification step, which was part of the extraction step.  The 
samples were cleaned using the Qiagen Kit to determine if a difference in amplification 
patterns would result.  The amplification chart (FIG A.2) shows amplification of all 
  12 
samples including concentration of 3 and 0.3mg, which were previously observed to be 
inhibited. TABLE A.2 shows the Ct values for each sample. The Ct values of the purified 
samples improved therefore it can be determined that initially co-purified DSS can be 
removed by processing samples through another purification cycle.  
The second assay designed with higher concentrations of DSS was used to determine if a 
certain concentration of DSS would remain inhibitory irrespective of purification.  
Concentration of 300, 30, 3, 0.3 and 0mg were added to fecal samples. Amplification for 
all samples containing DSS was either completely inhibited or was observed extremely 
late which is not considered significant amplification. Samples without DSS or 0mg of 
DSS are observed to amplify (FIG A.3). TABLE A.3 presents high Ct values obtained 
from the different concentrations of DSS.  The samples were purified and concentrations 
of 30, 3, 0.3 and 0mg of DSS amplified successfully (FIG A.4) with low Ct values 
(TABLE A.4).  Samples containing 300mg showed better Ct values compared to TABLE 
A.3, which contained Ct values of extracted samples, which had not undergone another 
purification cycle.  However, the Ct values do not indicate significant amplification.  
Samples from the original study were then purified using the Qiagen Kit and an increase 
in copy numbers was observed for day 21 and day 35 when DSS was administered, 
which indicates successful amplification (FIG 6).  Therefore, it can be stated that our 
samples contained less than 300mg but more than 0.3mg of DSS since they were able to 
amplify after the second round of amplification but not after the first.  
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FIG. 6.  Altered DSS Time-Points. The co-purified DSS in the DNA samples from the fecal samples was 
processed using another purification cycle and the copy number/ g fecal weight significantly increased on 
day 21 and day 35 when DSS was administered.  
 
 
3.2 Heparin and DSS comparison  
DSS was related to one of the known PCR inhibitors called heparin. Heparin, widely 
used as an anticoagulant, has been demonstrated to competitively inhibit DNA 
polymerase including Taq polymerase (5, 6, 13, 16).  The chemical structures of both 
molecules were compared for similarities and it was found that both molecules are acidic 
polysaccharides, anionic polysaccharides, contain sulfate and alcohol groups, have an 
ether linkage connecting the disaccharides, and both are similar in structure compared to 
DNA. The observed differences include the presence of carboxylic acid and amide in 
heparin but, not in DSS. Also, there are three sulfate groups present on the heparin 
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disaccharide compared to two sulfate groups on DSS.   It has previously been stated that 
presence of natural compounds such as polysaccharides, fats, carbohydrates and proteins 
in samples may impede DNA extractions and affect PCR amplification (7).  Due to 
heparin being a strong anionic polysaccharide, it has been suggested that heparin 
interferes with PCR possibly from a resulting conjugation between heparin and Taq 
DNA polymerase (16).  The importance of discussing sulfate groups is due to their 
reported inhibitory role in heparin (1, 13).  Studies have showed that the amount of 
sulfate concentration present in heparin is responsible for causing inhibition (1, 13).  
Heparinase I can reverse the inhibitory characteristics of Heparin by cleaving the 
polysaccharide into disaccharide units therefore decreasing the amount of sulfur (1, 13). 
Heparin to DNA ratios have been tested and reported that the degree of inhibition is 
directly correlated with the sulfate content (1).  In comparison, DSS was observed to be 
inhibitory at certain concentrations in our study. Also, in heparin inhibition can be 
overcome by using heparinase and similarly the Qiagen purification kit used in our study 
showed amplification on previously inhibited samples. Therefore it can be hypothesized 
that DSS inhibits Taq polymerase in qPCR via a competitive mechanism for the DNA 
template strand in similarity to Heparin.  However, further studies will be required to 
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CHAPTER IV 
SUMMARY AND CONCLUSION 
DSS is a well established model used to reproduce human UC in rodents in order to 
study the effects of inflammation on the GI microbiota. DNA extracted from fecal 
samples using the FastDNA®SPIN Kit for Soil showed reduced amplification, but only 
at DSS-treated time points in the study.  We show that DSS acts as a PCR inhibitor and 
developed methods to optimize its renewal from fecal samples. Therefore, it was 
hypothesized that DSS could be a potential PCR inhibitor. This hypothesis was tested 
using DSS-spiked fecal material. DNA was again extracted using FastDNA®SPIN Kit 
for Soil. A part of the DNA was analyzed using qPCR, while the other part underwent 
another purification step using Qiagen Dneasy Blood and Tissue Kit. DNA samples 
containing 0.03mg or less co-purified DSS do not inhibit amplification.  Concentrations 
of 30mg and 3mg DSS show successful amplification only post qiagen-purification. 
300mg DSS does not significantly amplify even after qiagen-purification. It is believed 
that DSS inhibits qPCR by competing with DNA for the Taq polymerase binding/active 
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FIG A.1. Amplification Chart of Extracted Samples in First Assay.  Samples with concentration 
of 3mg and 0.3 mg either failed to amplify or amplified really late which is not considered significant 
amplification. Negative control amplified really late and positive control amplified early as expected. 
Concentrations of 0.03 and 0.003 mg showed successful amplification.    
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  1 2 3 4 5 6 7 8 9 10 11 12
SampleType     3-A 3-A 3-A 3-B 3-B 3-B 3-C 3-C     
ThresholdCycle     N/A N/A N/A 39.97 38.26 N/A N/A N/A     
SampleType     3-C 0.3-A 0.3-A 0.3-A 0.3-B 0.3-B 0.3-B 0.3-C     
ThresholdCycle     40.84 N/A 35.78 N/A 40.59 40.91 N/A 14.99     
SampleType     0.3-C 0.03-A 0.03-A 0.03-A 0.03-B 0.03-B 0.03-B 0.03-C     
ThresholdCycle     16.77 15.65 14.01 13.92 14.07 14.20 14.41 14.49     
SampleType     0.03-C 0.03-C .003-A .003-A .003-A .003-B .003-B .003-B     
ThresholdCycle     14.71 14.61 14.72 14.05 N/A 14.75 14.32 14.20     
SampleType     .003-C .003-C .003-C 0-A 0-A 0-A 0-B 0-B     
ThresholdCycle     13.99 14.13 N/A 14.14 13.66 14.43 14.08 15.41     
SampleType   0-B 0-C 0-C 0-C               
ThresholdCycle   13.90 13.88 13.95 14.01               
SampleType     POS POS POS NTC NTC NTC         
ThresholdCycle     10.90 10.92 11.65 31.42 32.18 33.46         
SampleType                         
ThresholdCycle                         
The sample type in the table refers to sample identification in which the number represents concentration 
of DSS and the letter represents n which equals 3 therefore, A, B, and C are used. Each sample was run in 
triplicates. Ct > 30 indicate significant inhibition whereas, Ct < 30 indicates successful amplification. N /A 
indicates not amplified   
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FIG A.2. Amplification Chart of Qiagen-Purified Samples in First Assay. Samples from all 
concentrations showed successful amplification. Samples that were previously inhibited showed 
amplification at significant Ct values. Negative control amplified really late and positive control 
amplified early as expected.     
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e     3*-A 3*-A 3*-A 3*-B 3*-B 3*-B 3*-C 3*-C     
ThresholdC
ycle     13.39 14.13 12.77 14.37 13.14 14.30 N/A 17.60     
SampleTyp
e     3*-C 0.3*-A 0.3*-A 0.3*-A 0.3*-B 0.3*-B 0.3*-B 0.3*-C     
ThresholdC
ycle     14.24 14.05 14.03 13.98 14.16 14.30 14.31 14.93     
SampleTyp












B     
ThresholdC
ycle     14.71 14.49 14.40 14.21 14.38 14.39 14.49 14.48     
SampleTyp
















-B     
ThresholdC
ycle     14.30 14.31 14.44 14.21 13.99 13.93 14.22 14.65     
SampleTyp






-C 0*-A 0*-A 0*-A 0*-B 0*-B     
ThresholdC
ycle     14.58 14.60 14.59 14.20 14.86 14.39 14.42 14.56     
SampleTyp
e     0*-B 0*-B 0*-B 0*-C 0*-C 0*-C         
ThresholdC
ycle     14.32 14.01 13.97 14.29 14.24 14.21         
SampleTyp
e     POS POS POS     NTC NTC NTC     
ThresholdC
ycle     11.80 11.93 12.07     31.82 32.98 33.98     
SampleTyp
e                         
ThresholdC
ycle                         
 
The sample type in the table refers to sample identification in which the number represents concentration 
of DSS, (*) represents Qiagen-purified samples and the letter represents n which equals 3 therefore, A, 
B, and C are used. Each sample was run in triplicates. Ct > 30 indicate significant inhibition whereas, Ct 
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FIG A.3. Amplification Chart of Extracted Samples in Second Assay.  Samples lacking DSS or 
0mg were the only observed amplified samples. Concentrations of 300, 30, 0.3 and 0.03 were found 
to be inhibitory. They either lacked amplification or amplified really late  
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TABLE A.3 Ct Values of Extracted Samples in Second Assay 
 
 
  1 2 3 4 5 6 7 8 9 10 11 12
SampleType     300-A 300-A 300-A 300-B 300-B 300-B 300-C 300-C     
ThresholdCycle     N/A N/A N/A 35.11 39.01 35.06 N/A N/A     
SampleType     300-C 30-A 30-A 30-A 30-B 30-B 30-B 30-C     
ThresholdCycle     N/A 40.36 N/A 36.05 N/A 36.40 34.80 N/A     
SampleType     30-C 30-C 3-A 3-A 3-A 3-B 3-B 3-B     
ThresholdCycle     N/A N/A N/A 36.06 N/A 38.29 32.47 15.33     
SampleType     3-C 3-C 3-C 0.3-A 0.3-A 0.3-A 0.3-B 0.3-B     
ThresholdCycle     34.49 15.33 40.07 35.87 35.60 N/A 34.93 N/A     
SampleType     0.3-B 0.3-C 0.3-C 0.3-C 0-A 0-A 0-A 0-B     
ThresholdCycle     40.19 15.16 37.09 36.34 N/A 35.24 27.41 35.22     
SampleType     0-B 0-B 0-C 0-C 0-C           
ThresholdCycle     14.58 14.54 36.44 33.91 N/A           
SampleType     POS POS POS     NTC NTC NTC     
ThresholdCycle     N/A N/A 10.44     N/A 37.96 37.96     
SampleType                         
ThresholdCycle                         
The sample type in the table refers to sample identification in which the number represents concentration 
of DSS and the letter represents n which equals 3 therefore, A, B, and C are used. Each sample was run in 
triplicates. Ct > 30 indicate significant inhibition whereas, Ct < 30 indicates successful amplification. N/A 
indicates not amplified.     
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FIG A.4 Amplification Chart of Qiagen-Purified Samples in Second Assay. Samples containing 
DSS at concentrations, 30, 3,and 0.3mg showed successful amplification. Sample containing 300mg 
DSS showed better Ct values after Qiagen-purification however, they do not indicate significant 
amplification. Negative control amplified really late and positive control amplified early as expected.    
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C     
ThresholdCyc
le     35.10 35.66 36.16 20.75 20.17 20.85 21.98 31.90     
SampleType     
300*-
C 30*-A 30*-A 30*-A 30*-B 30*-B 30*-B 30*-C     
ThresholdCyc
le     22.67 14.29 14.17 14.10 14.13 14.15 14.52 14.08     
SampleType     30*-C 30*-C 3*-A 3*-A 3*-A 3*-B 3*-B 3*-B     
ThresholdCyc
le     14.20 14.23 14.28 14.10 14.26 14.44 14.52 14.63     










B     
ThresholdCyc
le     14.26 14.56 14.38 14.26 14.30 14.37 14.34 16.27     








C 0*-A 0*-A 0*-A 0*-B     
ThresholdCyc
le     14.86 14.35 14.25 13.73 14.07 14.08 14.12 14.20     
SampleType     0*-B 0*-B 0*-C 0*-C 0*-C           
ThresholdCyc
le     14.40 14.26 14.20 14.16 14.05           
SampleType                         
ThresholdCyc
le                         
SampleType     POS POS POS   NTC NTC NTC       
ThresholdCyc







The sample type in the table refers to sample identification in which the number represents concentration 
of DSS, (*) represent Qiagen-purified, and the letter represents n which equals 3 therefore, A, B, and C 
are used. Each sample was run in triplicates. Ct > 30 indicate significant inhibition whereas, Ct < 30 
indicates successful amplification. 
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